CSIMarket
 


Biotechnology & Pharmaceuticals Industry Profitability

Profitability Information & Trends 
  
Category:   Period:  

Biotechnology & Pharmaceuticals Industry Profitability Ratios 1 Q 2024 4 Q 2023 3 Q 2023 2 Q 2023 1 Q 2023
  2024 2023 2023 2023 2023
Gross Margin 69.16 % 70.28 % 67.35 % 73.79 % 74.39 %
Gross Margin Annual (TTM) 69.46 % 71.05 % 71.83 % 74.19 % 75.34 %
Gross Margin Ranking # 24 # 20 # 25 # 21 # 17
EBITDA Margin - 21.03 % 14.14 % 16.58 % 25.89 %
EBITDA Margin Annual (TTM) 14.5 % 24.96 % 27.71 % 31.97 % 33 %
EBITDA Margin Ranking # 103 # 20 # 57 # 51 # 20
Operating Margin - 8.59 % 1.03 % 5.51 % 4.98 %
Operating Margin Annual (TTM) 1.54 % 10.92 % 11.09 % 16.52 % 19 %
Operating Margin Ranking # 102 # 65 # 92 # 83 # 84
Pre-Tax Margin - 7.05 % - 1.02 % 11.63 %
Pre-Tax Margin Annual (TTM) - 10.13 % 10.3 % 15.97 % 18.64 %
Pre-Tax Margin Ranking # 103 # 59 # 96 # 92 # 38
Net Margin - 5.69 % - - 8.67 %
Net Margin Annual (TTM) - 5.95 % 6.31 % 12.13 % 14.63 %
Net Margin Ranking # 103 # 64 # 102 # 98 # 42


Comment on the 1 Q 2024 Gross Margin within the Biotechnology & Pharmaceuticals Industry

Biotechnology & Pharmaceuticals Industry increased Gross Margin through reduction in Cost of Sales and despite contraction in Gross Profit by -18.03 % and Revenue -19.07 %. Gross Margin in 1 Q 2024 was 69.16 %, below Industry average.

On the trailing twelve months basis gross margin in 1 Q 2024 fell to 69.46 %.

Within Healthcare sector only one Industry has achieved higher gross margin. Gross margin total ranking has deteriorated compare to previous quarter from 20 to 24.

Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.

Gross Margin Statistics
High Average Low
102.36 % 77.01 % 61.7 %
4. quarter 2013   4. quarter 2021

Gross Margin Industry Ranking
Within: No.
Healthcare Sector # 2
Overall # 24


Other Gross Margins
Compare Industry's gross margin to Cato's or S&P Gross profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking Gross Margins Lowest Ranking Gross Margins
Profitability for Cato's Suppliers Definiton of Gross Margin

Biotechnology & Pharmaceuticals Industry EBITDA Margin Statistics

 
EBITDA Margin Statistics
High Average Low
47.91 % 25.69 % -16.18 %
4. quarter 2019   4. quarter 2021

EBITDA Margin Industry Ranking
Within: No.
Healthcare Sector # 6
Overall # 103

EBITDA Margin Comment on the 1 Q 2024 within the Biotechnology & Pharmaceuticals Industry

Biotechnology & Pharmaceuticals Industry recorded operating loss compare to operating income achieved in previous quarter.

On the trailing twelve months basis Ebitda Margin in 1 Q 2024 fell to 14.5 %.

Within Healthcare sector 5 other industries have achieved higher ebitda margin. Ebitda margin total ranking has deteriorated compare to previous quarter from 20 to 103.

Other EBITDA Margins
Compare Industry's EBITDA margin to Cato's or S&P Gross profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking EBITDA Margins Lowest Ranking EBITDA Margins
Profitability for Industry's Suppliers Industry Net Cash Flow Margin


Biotechnology & Pharmaceuticals Industry Operating Margin Statistics

 

Operating Margin Comment on the 1 Q 2024 within the Biotechnology & Pharmaceuticals Industry

Biotechnology & Pharmaceuticals Industry recorded Operating Loss compare to Operating Profit achieved in previous quarter.

On the trailing twelve months basis operating margin in 1 Q 2024 fell to 1.54 %.

Within Healthcare sector 5 other industries have achieved higher operating margin. Operating margin total ranking has deteriorated compare to previous quarter from 65 to 102.



Operating Margin Statistics
High Average Low
41.3 % 20.63 % -27.37 %
4. quarter 2015   1. quarter 2024

Operating Margin Industry Ranking
Within: No.
Healthcare Sector # 6
Overall # 102

Biotechnology & Pharmaceuticals Industry Pre-Tax Margin Statistics

 


Pre-Tax Margin Statistics
High Average Low
38.85 % 16.84 % -33.11 %
4. quarter 2015   1. quarter 2024

Comment on the 1 Q 2024 Pre-Tax Margin in the Biotechnology & Pharmaceuticals Industry

Biotechnology & Pharmaceuticals Industry recorded Pre-Tax Loss compare to Pre-Tax Income achieved in previous quarter.



Within Healthcare sector 5 other industries have achieved higher Pre-Tax Margin. Pre-Tax Margin total ranking has deteriorated compare to previous quarter from 59 to 103.
Pre-Tax Margin Industry Ranking
Within: No.
Healthcare Sector # 6
Overall # 103

Pre-Tax Margins
Compare Industry's pre-tax margin to Cato's or S&P Net profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Cato's Competitors Industry Tax Rate


Biotechnology & Pharmaceuticals Industry Net Margin Statistics

 





Net Margin Comment on the 1 Q 2024 in the Biotechnology & Pharmaceuticals Industry

Biotechnology & Pharmaceuticals Industry recorded Net Loss compare to Net Profit achieved in previous quarter.



Within Healthcare sector 5 other industries have achieved higher Net margin. Net margin total ranking has deteriorated compare to previous quarter from 64 to 103.

Net Margin Statistics
High Average Low
32.97 % 12.26 % -32.22 %
4. quarter 2015   1. quarter 2024
Net Margin Industry Ranking
Within: No.
Healthcare Sector # 6
Overall # 103

Other Net Margins
Compare Industry's net margin to Cato's or S&P Net profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Cato's Suppliers Definiton of Net Margin





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com